Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grass Pollen Immunotherapy Cluster Regime Trial
NCT00135642Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Feb 1996
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of alutard-sq in seasonal allergic rhinitis (SAR), asthma, sponsored by Imperial College London. Started Feb 1996; status: completed.
02
Drugs
alutard-sq
03
Conditions
seasonal allergic rhinitis (SAR)asthma
Beyond the preview
Go deeper on NCT00135642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135642.